AO

Abu Olidh Hijbullah

Active Director Director DIN 08016827
DIN 08016827 First appointment Jan 2018 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Abu Olidh Hijbullah

Data last updated:

Abu Olidh Hijbullah is a Director at N.E. Pharmaceuticals Private Limited (since 2018). The company operates in Electrnoics. N.E. Pharmaceuticals Private Limited reported revenue of ₹14.8 Lakh (FY 2019).

DIN 08016827
Primary Designation Director
Industry Electrnoics
First Appointment 04 Jan 2018
Oldest Company Age 8 yrs
Largest company N.E. Pharmaceuticals Private Limited · ₹14.8 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
N.E. Pharmaceuticals Private Limited U52609AS2018PTC018298
Director04 Jan 20182018₹14.8 Lakh (FY 2019)Active

Board colleagues of Abu Olidh Hijbullah

NameDINCompanyDesignation
Abu Khalidh Saifullah08016822N.E. Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
N.E. Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abu Olidh Hijbullah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abu Olidh Hijbullah

Abu Olidh Hijbullah currently holds 1 directorship: N.E. Pharmaceuticals Private Limited (Director, since 04 Jan 2018, revenue ₹14.8 Lakh (FY 2019)).

Abu Olidh Hijbullah was first appointed on 04 Jan 2018 as Director at N.E. Pharmaceuticals Private Limited.

The current boards of Abu Olidh Hijbullah's companies include Abu Khalidh Saifullah (N.E. Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available